Ignite Creation Date:
2025-12-25 @ 12:36 AM
Ignite Modification Date:
2025-12-25 @ 10:46 PM
Study NCT ID:
NCT04676867
Status:
COMPLETED
Last Update Posted:
2022-12-07
First Post:
2020-12-17
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Effect of Dalcetrapib in Patients With Confirmed Mild to Moderate COVID-19
Sponsor:
DalCor Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-01-11
Start Date Type:
ACTUAL
Primary Completion Date:
2021-05-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-05-17
Completion Date Type:
ACTUAL
First Submit Date:
2020-12-17
First Submit QC Date:
None
Study First Post Date:
2020-12-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-08-31
Results First Submit QC Date:
None
Results First Post Date:
2022-12-07
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-11-10
Last Update Post Date:
2022-12-07
Last Update Post Date Type:
ACTUAL